- Sort by Sort ascending
- Titolo di lavoro Sort ascending
- Site
- Posizione
- Divisione
- Business
- Area funzionale
- Data di pubblicazione
| Titolo di lavoro Sort ascending | Site | Posizione | Divisione | Business | Area funzionale | Data di pubblicazione |
|---|---|---|---|---|---|---|
| Medical Science Liaison -BC | Beijing (Beijing) | Cina | International | Development | Research & Development | Feb 12, 2026 |
| Medical Science Liaison -BC | Beijing (Beijing) | Cina | International | Development | Research & Development | Feb 12, 2026 |
| Medical Science Liaison -BC | Beijing (Beijing) | Cina | International | Development | Research & Development | Feb 12, 2026 |
| Medical Science Liaison -BC | Beijing (Beijing) | Cina | International | Development | Research & Development | Feb 12, 2026 |
| Medical Science Liaison -BC | Beijing (Beijing) | Cina | International | Development | Research & Development | Feb 12, 2026 |
| Manager, Regulatory Affairs Cell & Gene Therapies | Schaftenau | Austria | Development | Development | Research & Development | Feb 11, 2026 |
| Director, Regulatory Affairs (Digital Medical Devices) | London (The Westworks) | Regno Unito | Development | Development | Research & Development | Feb 11, 2026 |
| Associate Director Congress Operations | Dublin (NOCC) | Irlanda | Development | Development | Research & Development | Feb 11, 2026 |
| Associate Director Engineering (m/f/d) | Schaftenau | Austria | Development | Development | Research & Development | Feb 11, 2026 |
| Medical Science Liaison (MSL) Onc Prostate Radioligand Therapies South Texas Remote | Houston (Texas) | USA | US | Marketing | Research & Development | Feb 11, 2026 |
| Associate Expert Science & Technology | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 10, 2026 |
| Associate Clinical Development Medical Director | Barcelona Gran Vía | Spagna | Development | Development | Research & Development | Feb 10, 2026 |
| Research Scientist I/II, Oligonucleotide Chemistry | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Feb 10, 2026 |
| International Program Regulatory Director (IPRD) | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 10, 2026 |
| Director, Strategic Projects Lead | Barcelona Gran Vía | Spagna | Development | Development | Research & Development | Feb 09, 2026 |
| Clinical Development Director - Renal | London (The Westworks) | Regno Unito | Development | Development | Research & Development | Feb 09, 2026 |
| Expert Science & Technology | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 09, 2026 |
| Senior Clinical Development Medical Director - Renal | London (The Westworks) | Regno Unito | Development | Development | Research & Development | Feb 09, 2026 |
| Senior Expert - Extractables and Leachables (m/f/d) | Schaftenau | Austria | Development | Development | Research & Development | Feb 09, 2026 |
| (Senior) Regulatory Affairs Manager | Beijing (Beijing) | Cina | Development | Development | Research & Development | Feb 08, 2026 |
| Principal Scientist, Biomarker Assay Development Bench Scientist | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Feb 06, 2026 |
| Medical Science Liaison - Radioligand Therapy | Bucuresti | Romania | International | Development | Research & Development | Feb 06, 2026 |
| AD, Cell Therapy Operations Manager - New York / Tri-State | Field Non-Sales (USA) | USA | US | Marketing | Research & Development | Feb 06, 2026 |
| Senior Expert - Medical Device Analytical Representative (m/f/d) | Schaftenau | Austria | Development | Development | Research & Development | Feb 05, 2026 |
| Central Monitor | Dublin (NOCC) | Irlanda | Development | Development | Research & Development | Feb 05, 2026 |
| Lead Central Monitor | Dublin (NOCC) | Irlanda | Development | Development | Research & Development | Feb 05, 2026 |
| Head of US Risk Management & Product Safety (Risk Evaluation and Mitigation Strategies-REMS) | East Hanover | USA | Development | Development | Research & Development | Feb 04, 2026 |
| Medical Scientific Liaison - Immunology | New South Wales (NSW) | Australia | International | Legal | Research & Development | Feb 04, 2026 |
| Medical Advisor | Hong Kong | Hong Kong Special Administrative Region, China | International | Development | Research & Development | Feb 04, 2026 |
| Senior Expert Science & Technology | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 03, 2026 |
| Clinical Development Medical Director (CDMD) Neuroscience | London (The Westworks) | Regno Unito | Development | Development | Research & Development | Feb 03, 2026 |
| Associate or Manager, PHAD Japan | Toranomon (NPKK Head Office) | Giappone | Development | Development | Research & Development | Feb 03, 2026 |
| Medical Science Liaison -BC | Guangzhou (Guangdong Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Changsha (Hunan Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison-CSU | Guangzhou (Guangdong Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Hefei (Anhui Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -Hema | Tianjin (Tianjin) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Tianjin (Tianjin) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Guangzhou (Guangdong Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Changsha (Hunan Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison-CSU | Guangzhou (Guangdong Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Hefei (Anhui Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -Hema | Tianjin (Tianjin) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Tianjin (Tianjin) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Guangzhou (Guangdong Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Changsha (Hunan Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison-CSU | Guangzhou (Guangdong Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Hefei (Anhui Province) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -Hema | Tianjin (Tianjin) | Cina | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Tianjin (Tianjin) | Cina | International | Development | Research & Development | Feb 02, 2026 |
Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122